Last reviewed · How we verify

NCT06082219

Ulcer Bleeding After Band Ligation of Esophageal Varices

Status unknown Last updated 16 October 2023
What this trial tests

trial in Esophageal Varices in 130 participants. Status unknown.

Timeline
1 January 2024
Primary endpoint
1 January 2025
1 March 2025

Quick facts

Lead sponsorAssiut University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment130
Start date1 January 2024
Primary completion1 January 2025
Estimated completion1 March 2025

Conditions studied

Sponsor

Assiut University

Who can join

Adults 18 to 80, any sex, with Esophageal Varices. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Primary Outcomes: assessment of incidence , risk factors and prognosis of post-banding ulcer bleeding following EVL in patients with liver cirrhosis. Secondary Outcomes: minimize post-banding ulcer bleeding

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Esophageal Varices

Currently open trials in the same condition.

Other Assiut University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06082219.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing